ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 25 | June 18, 2004

Download PDF Visit The Full Archive

Related Articles

Nexavar Improves PFS In Phase III Trial

January 25, 2013

In Brief: Evaluation Of Potential Immunoassay Components Sought; Promising Results Could Lead to Contract

September 19, 1975

Congressional Committee, SEC Probe ImClone’s Statements To Shareholders.

January 25, 2002

CT Finds Early Lung Tumors In Smokers, Former Smokers

March 31, 2006

Study Tests PARP Inhibitor ABT-888 For Several Cancers

September 25, 2009

Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

June 6, 2014